Inari Medical, Inc. (NARI)
NASDAQ: NARI · IEX Real-Time Price · USD
40.78
-0.74 (-1.78%)
At close: Apr 12, 2024, 4:00 PM
40.60
-0.18 (-0.44%)
After-hours: Apr 12, 2024, 5:23 PM EDT

Inari Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
493.63383.47276.98139.6751.136.83
Revenue Growth (YoY)
28.73%38.45%98.31%173.17%648.70%-
Cost of Revenue
59.0744.5124.7613.115.911.28
Gross Profit
434.56338.97252.23126.5645.225.55
Selling, General & Admin
361.06292.84190.3789.7537.210.7
Research & Development
87.5374.2251.0218.47.223.99
Operating Expenses
448.6367.06241.38108.1544.4214.69
Operating Income
-14.03-28.110.8418.420.8-9.14
Interest Expense / Income
0.20.290.31.140.920.89
Other Expense / Income
-18.47-2.21-0.143.51.070.13
Pretax Income
4.25-26.1910.6913.79-1.19-10.15
Income Tax
5.883.080.85000
Net Income
-1.64-29.279.8413.79-1.19-10.15
Net Income Growth
---28.64%---
Shares Outstanding (Basic)
5753503265
Shares Outstanding (Diluted)
5753565265
Shares Change
7.44%-4.96%7.83%775.66%16.43%-
EPS (Basic)
-0.03-0.550.200.43-0.20-2.01
EPS (Diluted)
-0.03-0.550.180.27-0.20-2.01
EPS Growth
---33.33%---
Free Cash Flow
29.73-23.9211.84-3.55-8.08-11.65
Free Cash Flow Per Share
0.52-0.450.24-0.11-1.37-2.30
Gross Margin
88.03%88.39%91.06%90.62%88.44%81.24%
Operating Margin
-2.84%-7.33%3.92%13.19%1.57%-133.84%
Profit Margin
-0.33%-7.63%3.55%9.87%-2.33%-148.67%
Free Cash Flow Margin
6.02%-6.24%4.27%-2.54%-15.80%-170.52%
Effective Tax Rate
138.53%-7.91%---
EBITDA
15.18-18.7715.2916.310.34-8.98
EBITDA Margin
3.07%-4.90%5.52%11.68%0.67%-131.54%
Depreciation & Amortization
10.747.124.311.390.610.28
EBIT
4.44-25.8910.9814.92-0.27-9.27
EBIT Margin
0.90%-6.75%3.96%10.69%-0.53%-135.69%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).